Levy Health has raised $4.5 million in seed funding to further develop its clinical decision support platform for fertility diagnosis. The round was led by XYZ Ventures, with participation from Atlantic Labs and Possible Ventures. Founded in 2022 by Caroline Mitterdorfer, Silvia Hecher, and Dr. Theresa Vilsmaier, Levy Health aims to speed up the process of diagnosing fertility issues in women. The…
Maven Clinic, the world’s largest virtual clinic for women’s and family health, has announced a $125 million Series F funding round. This investment brings Maven’s total funding to over $425 million and establishes it as the highest valued digital health company in the women’s and family health sector. The funding round was led by StepStone Group, with participation from existing investors including…
Rezilient Health, a tech-enabled healthcare company, has raised $10 million in a Series A funding round. Govo Venture Partners led the round, with participation from Bridge Ventures, Acorn Pacific Ventures, The Council, and several individual investors including Jim McKelvey, Mark and Robyn Jones, Jeremy Friese, and David Karandish. The company plans to use the funding to expand its concierge healthcare services for…
Marlow, a Canada-based period care brand, has raised additional funding in a round led by Love x Money Ventures, with participation from Dream Ventures and other angel investors. This funding will allow Marlow to grow its footprint the U.S. market, further develop its Amazon channel, and create new products. The company has now raised a total of $1.9 million, including non-dilutive funding…
Flora Fertility, an insurtech company, has raised $1.5 million in a pre-seed funding round. The round was led by Highline Beta, with co-investments from Cartography Capital, Everywhere Ventures, and angel investors from the insurance, technology, and financial services industries. The company plans to use this investment to launch a private fertility insurance product in the United States and Canada. Flora Fertility aims…
Cartherics, an Australian biotech company developing immune cell therapies, has announced the successful completion of an oversubscribed private financing round, raising over AU$15 million. This funding will primarily support the clinical trial of CTH-401, the company’s lead cell therapy for ovarian cancer, and expand its pipeline to include other diseases. Based in Melbourne, Cartherics focuses on developing cell-based immunotherapies for cancer treatment.…
In the world of women’s health, few areas have been as overlooked and underserved as pelvic health. For decades, patients suffering from chronic pelvic pain and related conditions have faced outdated treatments, limited options, and a lack of understanding from the medical community. Enter Hyivy Health, a Canadian startup that’s not just disrupting the status quo – it’s completely redefining how we…
Helaina, a biotechnology company focused on human equivalent bioactive proteins, has announced a $45 million Series B funding round bringing the company’s total equity funding to $83 million. Avidity Partners led the round, with participation from Spark Capital, Ingeborg Investments, Tom Williams of Heron Rock, Barrel Ventures, Siam Capital, Relish Works, CF Private Equity, and Primary Venture Partners, among others. The funding…
